Doctor of Dentistry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Steven Reff

Dentist, General Practice Westfield, NJ Doctor of Dentistry

NPI 1548557093 CMS profile 1090462

131 S Euclid Ave, Westfield, NJ 07090

Open in the dashboard

General payments

$4,028

182 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Steven Reff of Westfield, NJ is reported in the CMS Open Payments database as having received $4,028 across 182 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $15 1
2023 General $1,810 86
2022 General $1,446 58
2021 General $613 35
2019 General $143 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Reff
  • Dentist, General Practice median
  • Middle half of Dentist, General Practice
  • National median

In program year 2025, general payments to Steven Reff were reported at $0. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.

Show as a table
Year Steven Reff Dentist, General Practice median Middle half National median
2019 $143 $61 $23–$158 $163
2020 $0 $73 $24–$142 $114
2021 $613 $75 $25–$184 $132
2022 $1,446 $75 $27–$198 $149
2023 $1,810 $77 $28–$200 $160
2024 $15 $74 $27–$187 $164
2025 $0 $75 $27–$200 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Implant Direct Sybron International LLC $2,203 95 payments
  2. Nobel Biocare USA $1,810 86 payments
  3. Philips Electronics North America Corporation $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $3,935 181 payments
  2. Education $93 1 payment
Products named General payments · program years 2019–2024
  1. LEGACY SYSTEM $2,203 95 payments
  2. NOBELACTIVE $1,810 86 payments
  3. (E17) Power Toothbrush Und $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

571

Median for Dentist: 47

Drug cost

$2,101

Median for Dentist: $159

Branded share of claims

32.7%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 228 $725
Methylprednisolone Generic 80 $493
Acetaminophen-Codeine Acetaminophen With Codeine Brand 106 $310
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 60 $222
Clindamycin Hcl Generic 30 $157
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 21 $133
Ibuprofen Generic 46 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, General Practice in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record